| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |